A decade?s studies on metastasis of hepatocellular carcinoma
Top Cited Papers
- 18 December 2003
- journal article
- review article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 130 (4) , 187-196
- https://doi.org/10.1007/s00432-003-0511-1
Abstract
Metastasis remains one of the major challenges before hepatocellular carcinoma (HCC) is finally conquered. This paper summarized a decade’s studies on HCC metastasis at the Liver Cancer Institute of Fudan University. We have established a stepwise metastatic human HCC model system, which included a metastatic HCC model in nude mice (LCI-D20), a HCC cell line with high metastatic potential (MHCC97), a relatively low metastatic potential cell clone (MHCC97L) and several stepwise high metastatic potential cell clones (MHCC97H, HCCLM3, and HCCLM6) from their parent MHCC97 cell. Endeavors have been made for searching human HCC metastasis-related chromosomes/proteins/genes. Monogene-based studies revealed that HCC invasion/metastasis was similar to that of other solid tumors, and the biological characteristics of small HCC were only slightly better than that of large HCC. Using comparative genomic hybridization (CGH), fluorescence in situ hybridization (FISH), genotyping, cDNA microarray, and 2-dimensional gel electrophoresis, we obtained some interesting results. In particular, in collaboration with the National Institute of Health (NIH) in the United States, we generated a molecular signature that can classify metastatic HCC patients, identified osteopontin as a lead gene in the signature, and found that genes favoring metastasis progression were initiated in the primary tumors. We also found that chromosome 8p deletion, particularly in the region of 8p23, was associated with HCC metastasis. Cytokeratin 19 was identified as one of the proteins, which was found in MHCC97H, but not in MHCC97L cells. Experimental interventions using the high metastatic nude mice model have provided clues for the prevention of HCC metastasis. Translation from workbench to bedside demonstrated that serum VEGF, microvessel density, and p53 scoring may be of value for the prediction of postoperative metastatic recurrence. Interferon alpha proved effective for the prevention of recurrence both experimentally and clinically. In conclusion, HCC metastasis that probably initiated in the primary tumor is a multigene-involved, multistep, and changing process. The further elucidation of the mechanism underlying HCC metastasis will provide a more solid basis for the prediction and prevention of the metastatic recurrence of HCC.Keywords
This publication has 81 references indexed in Scilit:
- Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarrayZeitschrift für Krebsforschung und Klinische Onkologie, 2003
- Inhibitory effects of synthetic β peptide on invasion and metastasis of liver cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2000
- Genomic analysis of metastasis reveals an essential role for RhoCNature, 2000
- Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombusZeitschrift für Krebsforschung und Klinische Onkologie, 2000
- Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma.1999
- Establishment and characteristics of human hepatocellular carcinoma cells with metastasis to lymph nodes.1999
- The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.1999
- Adjuvant intra-arterial lipiodol-iodine-131 for resectable hepatocellular carcinoma: a prospective randomised trialThe Lancet, 1999
- Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1Zeitschrift für Krebsforschung und Klinische Onkologie, 1999
- Expression of the integrin? 5 subunit and its mediated cell adhesion in hepatocellular carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 1997